Conference

13th Annual Outsourcing in Clinical Trials: Medical Devices Europe 2025

Jan 28 - 29, 2025

Munich, Germany

OCT Medical Devices Europe is a premier event focused on optimizing clinical trials and advancing medical device development across Europe. The conference brings together clinical trial experts, regulatory professionals, and industry leaders to explore best practices, emerging technologies, and regulatory updates in the medical device landscape. With a spotlight on innovation, the event aims to streamline trial processes and enhance patient outcomes. Through keynote sessions, interactive workshops, and panel discussions, attendees gain actionable insights into overcoming common challenges in clinical research, such as patient recruitment, compliance, and data integration. Whether you’re managing trials, developing medical devices, or navigating regulatory frameworks, OCT Med Europe provides a collaborative platform for driving excellence in clinical trial execution.

Stay ahead in the Pharma game

Register for this event now!

About the Organiser

Arena International Events Group

Day and Timing

Tuesday, Jan 28 - 29

Location

Munich, Germany

Entry Fees

Free

Frequency

Annually

Event Type

Conference

Duration

2 days

Website

arena-international.com
Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news

Stay ahead in the Pharma game

Register for this event now!

Day and Timing

Tuesday, Jan 28 - 29

Location

Munich, Germany

Entry Fees

Free

Frequency

Annually

Event Type

Conference

Duration

2 days

Website

arena-international.com

About the Organiser

Arena International Events Group

Ad
Advertisement

More Events

Conference

9th Biologics Festival India 2025

Mar 04 - 05, 2025

Pune

Conference

Annual Vaccines World Summit 2025

Mar 04 - 05, 2025

Pune

Conference

World Vaccine Congress 2025

Apr 21 - 24, 2025

Washington D.C

View All

News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news